StockData
Radiopharm Theranostics Ltd logo

Radiopharm Theranostics Ltd (RADX) stock

RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 30, 2026Score 6/30
$0.69+0.01 (+2.10%)

Close on Nov 18, 2026Market cap $8.09MP/E –Yield –

Radiopharm Theranostics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2023 it was -$23.25M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Jun 30, 2023-$23.25M–

More Radiopharm Theranostics figures

See a number that looks wrong?